StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) stock

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Lipella Pharmaceuticals's price to sales ratio was 0.0× on Oct 19, 2026, against 4.1× a year earlier. Over the last 4 years it ranged from 0.0× to 76.1×, with a median of 6.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.0×−2.1
2025Dec 31, 20252.1×−4.7
2024Dec 31, 20246.9×−5.5
2023Dec 29, 202312.3×−34.3
2022Dec 30, 202246.7×–

More Lipella Pharmaceuticals figures

See a number that looks wrong?